Analyzing the clinical actionability of germline pharmacogenomic findings in oncology
Sign Up to like & getrecommendations! Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31382
Abstract: Germline and tumor pharmacogenomics impact drug responses, but germline markers less commonly guide oncology prescribing. The authors hypothesized that a critical number of clinically actionable germline pharmacogenomic associations exist, representing clinical implementation opportunities. read more here.
Keywords: analyzing clinical; germline pharmacogenomic; actionability germline; pharmacogenomic findings ... See more keywords